These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2212952)

  • 1. Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genes.
    Nickerson CL; Hanson J; David CS
    J Exp Med; 1990 Oct; 172(4):1255-61. PubMed ID: 2212952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HLA-B27 in transgenic mice is controlled by gene(s) mapping between H-2D and H-2L loci.
    Nickerson-Nutter CL; Hogen KL; David CS
    Immunogenetics; 1992; 35(3):199-204. PubMed ID: 1537610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HLA-B27 in transgenic mice is controlled by the H-2D gene(s).
    Nickerson-Nutter CL; David CS
    Int J Cancer Suppl; 1991; 6():14-7. PubMed ID: 2066179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchy in the assembly of HLA-B27 and HLA-Cw3 molecules in transgenic mice.
    Pedrinaci S; Hanson J; David C
    Immunogenetics; 1994; 39(2):130-7. PubMed ID: 8276456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of H-2 genes on expression of HLA-B27 and Yersinia-induced arthritis.
    Nickerson CL; Hogen KL; Luthra HS; David CS
    Scand J Rheumatol Suppl; 1990; 87():85-90; discussion 90. PubMed ID: 2259892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The H-2D genes influence expression of HLA-B27 in transgenic mice.
    Nickerson CL; David CS
    Transplant Proc; 1991 Feb; 23(1 Pt 1):421-2. PubMed ID: 1990576
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination.
    Rodriguez M; Nickerson C; Patick AK; David CS
    J Immunol; 1991 Apr; 146(8):2596-602. PubMed ID: 2016520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular inflammation in HLA-B27 transgenic mice reveals a potential role for MHC class I in corneal immune privilege.
    Lin A; Guo X; Inman RD; Sivak JM
    Mol Vis; 2015; 21():131-7. PubMed ID: 25684978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal anti-viral immune response in mice is corrected in HLA-B27.2-transgenic mice.
    Kievits F; Lokhorst W; Ivanyi P
    Eur J Immunol; 1990 May; 20(5):1189-92. PubMed ID: 1694133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human beta 2-microglobulin.
    Taurog JD; Lowen L; Forman J; Hammer RE
    J Immunol; 1988 Dec; 141(11):4020-3. PubMed ID: 3053904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    J Exp Med; 1995 Oct; 182(4):1153-8. PubMed ID: 7561688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition.
    Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P
    J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class-I-transgenic mice as model system to study MHC-restricted antigen recognition in man.
    Weiss EH; Schliesser G; Botteron C; McMichael A; Riethmüller G; Kievits F; Ivanyi P; Brem G
    Scand J Rheumatol Suppl; 1990; 87():91-6. PubMed ID: 2259893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA expression and function in single and double HLA-B27-transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Boerenkamp WJ; Ivanyi P
    Tissue Antigens; 1989 Jul; 34(1):50-63. PubMed ID: 2683209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of HLA-B27 by mouse cytotoxic T-cell clones: a transgenic mouse model.
    Reboul M; Frangoulis B; Rocca A; Degos L; Pla M
    Immunogenetics; 1991; 34(3):196-200. PubMed ID: 1894313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and regulation of a human transgene, HLA-B27, in mouse placental and embryonic cell lines.
    Hunt JS; Banerjee S; Pace JL
    Mol Hum Reprod; 1998 Aug; 4(8):817-25. PubMed ID: 9733441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
    Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
    J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
    Khare SD; Hansen J; Luthra HS; David CS
    J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface.
    Carreno BM; Hansen TH
    Eur J Immunol; 1994 Jun; 24(6):1285-92. PubMed ID: 8206088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosses of two independently derived transgenic mice demonstrate functional complementation of the genes encoding heavy (HLA-B27) and light (beta 2-microglobulin) chains of HLA class I antigens.
    Krimpenfort P; Rudenko G; Hochstenbach F; Guessow D; Berns A; Ploegh H
    EMBO J; 1987 Jun; 6(6):1673-6. PubMed ID: 3301331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.